Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health and Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research on agency’s warning to consumers about genetic tests that claim to predict patients’ responses to specific medications - FDA Press Releases

FDA warns consumers about concerns with pharmacogenetic tests whose claims have not been reviewed by FDA

from Food and Drug Administration--Press Releases https://ift.tt/2QbQXuL
via IFTTT